Innoviva (INVA) Income towards Parent Company (2010 - 2026)

Innoviva (INVA) posted Income towards Parent Company of $186.6 million for Q1 2026, up 1191.71% on a QoQ basis from -$17.1 million in Q4 2025, and up 500.51% year-over-year from $31.1 million in Q1 2025.

Innoviva (INVA) Income towards Parent Company (2010 - 2026) Analysis & Trends

Innoviva's Income towards Parent Company history runs 16 years deep, the most recent figure standing at $186.6 million for Q1 2026.

  • Quarterly Income towards Parent Company rose 500.51% year-over-year to $186.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $340.2 million (up 463.02% YoY) and the FY2025 annual result came in at $326.9 million, up 1329.41% from the prior year.
  • Income towards Parent Company was $186.6 million for Q1 2026 at Innoviva, up from -$17.1 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $288.6 million in Q3 2022 and bottomed at -$175.8 million in Q4 2023.
  • A 5-year average of $34.9 million and a median of $21.4 million in 2022 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2024 — Income towards Parent Company sank 2757.85% — and 2025, when it soared 3359.15%.
  • Innoviva's Income towards Parent Company stood at -$15.9 million in 2022, then sank by 1005.62% to -$175.8 million in 2023, then surged by 91.16% to -$15.5 million in 2024, then fell by 9.99% to -$17.1 million in 2025, then soared by 1191.71% to $186.6 million in 2026.
  • Business Quant data shows INVA's Income towards Parent Company at $186.6 million in Q1 2026, -$17.1 million in Q4 2025, and $107.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Innoviva 1.58 Bn 979.49 Mn 75.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 186.60 Mn
Dec 31, 2025 -17.09 Mn
Sep 30, 2025 107.03 Mn
Jun 30, 2025 63.69 Mn
Mar 31, 2025 -46.59 Mn
Dec 31, 2024 -15.54 Mn
Sep 30, 2024 3.09 Mn
Jun 30, 2024 -34.69 Mn
Mar 31, 2024 36.52 Mn
Dec 31, 2023 -175.83 Mn
Sep 30, 2023 118.19 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 34.84 Mn
Dec 31, 2022 -15.90 Mn
Sep 30, 2022 288.58 Mn
Jun 30, 2022 21.40 Mn
Mar 31, 2022 37.86 Mn
Dec 31, 2021 -44.88 Mn
Sep 30, 2021 323.19 Mn
Jun 30, 2021 110.85 Mn